What does DR. PETER POTARGENT do?

DR. PETER POTARGENT is a general practice in Genk. Private Limited, started on 14 September 1998, 1 establishment.

What is the address of DR. PETER POTARGENT?

The registered office of DR. PETER POTARGENT is located at Hooiweg 134 box B1, 3600 Genk.

Is DR. PETER POTARGENT still active?

Yes. According to the CBE (30 September 2026) DR. PETER POTARGENT is active, legal situation “Normale toestand”, started on 14 September 1998.

Is DR. PETER POTARGENT registered on Peppol?

No, DR. PETER POTARGENT is currently not registered on the Peppol network.

What is the enterprise number of DR. PETER POTARGENT?

The enterprise number of DR. PETER POTARGENT is BE0464129360.

When was DR. PETER POTARGENT founded?

DR. PETER POTARGENT was founded on 14 September 1998.

Who are the directors of DR. PETER POTARGENT?

According to the 2025 annual accounts, the directors of DR. PETER POTARGENT are: Peter Potargent.

Is DR. PETER POTARGENT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 September 1998; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. PETER POTARGENT make in 2025?

DR. PETER POTARGENT posted a profit after taxes of € 67,888 in financial year 2025.

What is the revenue of DR. PETER POTARGENT?

As a small company, DR. PETER POTARGENT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 486,703.

DR. PETER POTARGENT (Private Limited) - Genk

Dossier DR. PETER POTARGENT, printed on 30 September 2026 from databakkes.be/en/0464129360/dr-peter-potargent. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. PETER POTARGENT from Genk, company number BE0464129360, closed financial year 2025 with a result of € 67,888 after tax. For that financial year DR. PETER POTARGENT recorded a gross margin of € 486,703 and equity of € 508,236. Compared with financial year 2024, the result moved from € 93,308 to € 67,888. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Growing

€ 508,236

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 67,888

▼ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 287,679

▲ 84% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 25,714 paid out

38 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 292,853

▲ 25% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 51,146

▲ € 44,228 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 317,521

▲ 6% vs 2024

€ 55,064 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 25,281

▼ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 44,004

▲ 41% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 395,838 Gross margin 2022: € 395,838 First fiscal year in the series	€ 404,306 Gross margin 2023: € 404,306 ▲ 2% vs 2022 (€ 395,838) Favourable step	€ 456,103 Gross margin 2024: € 456,103 ▲ 13% vs 2023 (€ 404,306) Favourable step	€ 486,703 Gross margin 2025: € 486,703 ▲ 7% vs 2024 (€ 456,103) Favourable step	▲ 7%
Profit after taxes	€ -6,393 Profit after taxes 2022: € -6,393 First fiscal year in the series	€ -19,883 Profit after taxes 2023: € -19,883 ▼ € 13,490 vs 2022 (€ -6,393) Unfavourable step	€ 93,308 Profit after taxes 2024: € 93,308 ▲ € 113,191 vs 2023 (€ -19,883) Favourable step	€ 67,888 Profit after taxes 2025: € 67,888 ▼ 27% vs 2024 (€ 93,308) Unfavourable step	▼ 27%
Equity	€ 458,353 Equity 2022: € 458,353 First fiscal year in the series	€ 438,469 Equity 2023: € 438,469 ▼ 4% vs 2022 (€ 458,353) Unfavourable step	€ 466,062 Equity 2024: € 466,062 ▲ 6% vs 2023 (€ 438,469) Favourable step	€ 508,236 Equity 2025: € 508,236 ▲ 9% vs 2024 (€ 466,062) Favourable step	▲ 9%
Total debts	€ 433,320 Total debts 2022: € 433,320 First fiscal year in the series	€ 387,839 Total debts 2023: € 387,839 ▼ 10% vs 2022 (€ 433,320) Favourable step	€ 404,542 Total debts 2024: € 404,542 ▲ 4% vs 2023 (€ 387,839) Unfavourable step	€ 386,806 Total debts 2025: € 386,806 ▼ 4% vs 2024 (€ 404,542) Favourable step	▼ 4%
Cash	€ 132,290 Cash 2022: € 132,290 First fiscal year in the series	€ 134,115 Cash 2023: € 134,115 ▲ 1% vs 2022 (€ 132,290) Favourable step	€ 156,457 Cash 2024: € 156,457 ▲ 17% vs 2023 (€ 134,115) Favourable step	€ 287,679 Cash 2025: € 287,679 ▲ 84% vs 2024 (€ 156,457) Favourable step	▲ 84%
Land & buildings	€ 409,482 Land & buildings 2022: € 409,482 First fiscal year in the series	€ 397,180 Land & buildings 2023: € 397,180 ▼ 3% vs 2022 (€ 409,482) Unchanged	€ 375,690 Land & buildings 2024: € 375,690 ▼ 5% vs 2023 (€ 397,180) Unchanged	€ 383,174 Land & buildings 2025: € 383,174 ▲ 2% vs 2024 (€ 375,690) Unchanged	▲ 2%
Retained profit	€ 439,761 Retained profit 2022: € 439,761 First fiscal year in the series	€ 419,877 Retained profit 2023: € 419,877 ▼ 5% vs 2022 (€ 439,761) Unfavourable step	€ 447,470 Retained profit 2024: € 447,470 ▲ 7% vs 2023 (€ 419,877) Favourable step	€ 489,644 Retained profit 2025: € 489,644 ▲ 9% vs 2024 (€ 447,470) Favourable step	▲ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 65,714 Dividend 2024: € 65,714 Unchanged (€ 0) Unchanged	€ 25,714 Dividend 2025: € 25,714 ▼ 61% vs 2024 (€ 65,714) Unchanged	▼ 61%
Bank debt	€ 340,984 Bank debt 2022: € 340,984 First fiscal year in the series	€ 324,376 Bank debt 2023: € 324,376 ▼ 5% vs 2022 (€ 340,984) Favourable step	€ 299,677 Bank debt 2024: € 299,677 ▼ 8% vs 2023 (€ 324,376) Favourable step	€ 317,521 Bank debt 2025: € 317,521 ▲ 6% vs 2024 (€ 299,677) Unfavourable step	▲ 6%
Balance sheet total	€ 891,673 Balance sheet total 2022: € 891,673 First fiscal year in the series	€ 826,308 Balance sheet total 2023: € 826,308 ▼ 7% vs 2022 (€ 891,673) Unchanged	€ 870,605 Balance sheet total 2024: € 870,605 ▲ 5% vs 2023 (€ 826,308) Unchanged	€ 895,042 Balance sheet total 2025: € 895,042 ▲ 3% vs 2024 (€ 870,605) Unchanged	▲ 3%

Key figures of DR. PETER POTARGENT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. PETER POTARGENT?

What happened at DR. PETER POTARGENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 67,888 (▼ 27% vs 2024). Source: NBB ↗
1998 Peter Potargent became a director. NBB
Sep 14, 1998 Start of the company according to the CBE. KBO
Sep 10, 1998 New establishment in Genk. KBO

In short

From € 6,393 loss in 2022 to € 67,888 profit in 2025.

Paid € 73,849 in corporate taxes since 2022.

Best year ever: 2024, with € 93,308 profit.

Paid out € 91,429 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. PETER POTARGENT? We notify you, reason included.

Follow DR. PETER POTARGENT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Peter Potargent

DR. PETER POTARGENT

Behind DR. PETER POTARGENT is Peter Potargent.

See the full network in the app

Directors

According to the 2025 annual accounts

Peter Potargent

Director

since 1998

Establishments

Establishment units

Physical locations of this company

Registered office

Hooiweg 134 box B1

3600 Genk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0464.129.360

VAT number

BE 0464.129.360

Registered office

Hooiweg 134 bus B1, 3600 Genk

Names & denominations

DR. PETER POTARGENT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 September 1998

Peppol

Not registered

Activities · NACE

Activiteiten van huisartspraktijken

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. PETER POTARGENT

Warning lights

Financials

What happened to DR. PETER POTARGENT?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions